@misc{indiciae3af718d0e00b,
  title = {A Reanalysis of the FDA's Benefit--Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection},
  author = {Paul S. Bourdon and Ram Duriseti and H. Christian Gromoll and Dyana K. Dalton and Kevin Bardosh and Allison E. Krug},
  year = {2026},
  url = {https://arxiv.org/abs/2410.11811},
  note = {Source identifier: 2410.11811}
}